Skip to main content

CHASE INVESTMENT COUNSEL CORP

Position in ABBV — AbbVie Inc.

CIK 19475 CHARLOTTESVILLE, VA

Position in ABBV

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$7,555,491
+$904,430 QoQ
Shares Held
30,025
-1.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.61%
of 13F equity value
Holder Rank
#1,063
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

CHASE INVESTMENT COUNSEL CORP holds $12,873,117 across 6 Drug Manufacturers - General names. ABBV ranks #1 (58.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABBV
AbbVie Inc.
This page
30,025 $7,555,491

All Filings in ABBV

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,555,491 30,025
2026-03-31 $6,651,061 30,581
2025-12-31 $8,198,221 35,880
2025-09-30 $8,074,262 34,872
2025-06-30 $906,196 4,882
2025-03-31 $1,022,876 4,882
2024-12-31 $870,730 4,900
2024-09-30 $971,601 4,920
2024-06-30 $847,651 4,942
2024-03-31 $816,718 4,485
2023-12-31 $666,990 4,304
2023-09-30 $641,554 4,304
2023-06-30 $570,985 4,238
2023-03-31 $984,587 6,178
2022-12-31 $5,024,454 31,090
2022-09-30 $6,343,704 47,267
2022-06-30 $7,307,876 47,714
2022-03-31 $8,214,762 50,674
2021-12-31 $6,624,715 48,927
2021-09-30 $2,435,704 22,580
2021-06-30 $2,511,984 22,301
2021-03-31 $2,413,414 22,301
2020-12-31 $2,338,655 21,826
2020-09-30 $1,911,739 21,826
2020-06-30 $2,133,549 21,731
2020-03-31 $283,045 3,715